Related Experiment Video

Updated: Jan 28, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer

Qiuli Wang1, Muwen Yang1, Ye Zhang2

  • 1Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China.

Current Gene Therapy
|March 9, 2019
PubMed
Abstract

Insights

Combined gene therapy using Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK) and CD40 ligand (CD40L) in an adenovirus vector selectively kills breast cancer cells. This enhanced therapy shows improved tumor reduction and apoptosis induction without harming normal tissues.

Area of Science:

  • Oncolytic virotherapy
  • Cancer gene therapy
  • Molecular oncology

Background:

  • Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK) suicide gene therapy selectively kills tumor cells.
  • Exogenous CD40 ligand (CD40L)-CD40 interaction via adenovirus also targets cancer cells.
  • Both methods offer tumor selectivity without damaging normal tissues.

Purpose of the Study:

  • To investigate the combined therapeutic effect of Dm-dNK suicide gene and CD40L gene therapy.
  • To evaluate this combined therapy using a selective oncolytic adenovirus vector.
  • To assess the efficacy against breast carcinoma cells in vitro and in vivo.

Main Methods:

  • Generated a series of conditionally replicating adenoviruses: P74-dNK, P74-CD40L, and P74-dNK-CD40L.
  • Treated breast cancer cell lines (MDA-MB-231, MCF-7) and a normal cell line (MRC5) with adenoviruses.
  • Assessed cytotoxicity (MTT assay), apoptosis (flow cytometry), and in vivo tumor growth in a mouse xenograft model.

Main Results:

  • Co-expression of Dm-dNK and CD40L reduced proliferation and increased apoptosis in cancer cells (MDA-MB-231, MCF-7).
  • The combined therapy was selective, not affecting normal MRC5 cells.
  • Significant tumor volume reduction was observed with combined treatment compared to single treatments.

Conclusions:

  • Combined gene therapy with Dm-dNK and CD40L via adenovirus enhances selective tumor cell killing.
  • This approach offers a promising strategy for improved cancer treatment.
  • The synergistic effect of Dm-dNK and CD40L warrants further investigation in cancer therapy.
Keywords:
CD40 ligandOVsPCRSuicide genetic therapyadenoviridaebreast neoplasms.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

13.1K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K